Further, plasma NFL/Aβ1–42 was correlated with the currently approved AD-CSF biomarkers (Aβ1–42, t-Tau, and p-Tau181) and neuroimaging biomarkers (Aβ-PET and MRI). The gene discussed is NEFL; the disease is Alzheimer disease.